Charts Dianthus Therapeutics, Inc.

Equities

End-of-day quote Nasdaq Other stock markets 2024-09-17			5-day change	1st Jan Change
25.99 ^USD	-1.63%		-5.73%	+149.90%

Aug. 09	Wedbush Adjusts Dianthus Therapeutics' PT to $36 From $38, Keeps Outperform Rating	MT
Aug. 08	Dianthus Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

ProRealTime Chart